Difficulty: Medium
Average Score: 90%
Practice
Which of the following compounds is incorrectly matched with its mechanism of action?
Correct answer
D
Rationale
The correct answer is D) Pioglitazone: Competitively blocks the binding of estrogens to their receptor.
Pioglitazone is a thiazolidinedione used in the treatment of type 2 diabetes mellitus. It functions by activating peroxisome proliferator-activated receptor gamma (PPAR-╬│) to improve insulin sensitivity in target tissues, not by blocking estrogen receptors.
A) Flutamide competitively blocks androgen receptors, making it an androgen receptor antagonist used in conditions like prostate cancer.
B) Finasteride inhibits 5╬▒-reductase, an enzyme responsible for converting testosterone to dihydrotestosterone, used in conditions like benign prostatic hyperplasia and male pattern baldness.
C) Miglitol inhibits ╬▒-glucosidase in the small intestine, reducing carbohydrate digestion and absorption, used in managing postprandial hyperglycemia in diabetes.
Understanding the mechanisms of action of these drugs is essential for healthcare professionals to make informed decisions about their appropriate use in clinical practice. This knowledge helps ensure safe and effective patient care while minimizing the risk of adverse effects and drug interactions.
Pioglitazone is a thiazolidinedione used in the treatment of type 2 diabetes mellitus. It functions by activating peroxisome proliferator-activated receptor gamma (PPAR-╬│) to improve insulin sensitivity in target tissues, not by blocking estrogen receptors.
A) Flutamide competitively blocks androgen receptors, making it an androgen receptor antagonist used in conditions like prostate cancer.
B) Finasteride inhibits 5╬▒-reductase, an enzyme responsible for converting testosterone to dihydrotestosterone, used in conditions like benign prostatic hyperplasia and male pattern baldness.
C) Miglitol inhibits ╬▒-glucosidase in the small intestine, reducing carbohydrate digestion and absorption, used in managing postprandial hyperglycemia in diabetes.
Understanding the mechanisms of action of these drugs is essential for healthcare professionals to make informed decisions about their appropriate use in clinical practice. This knowledge helps ensure safe and effective patient care while minimizing the risk of adverse effects and drug interactions.